Immediate Impact
3 by Nobel laureates 1 from Science/Nature 53 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Drug resistance in ovarian cancer: from mechanism to clinical trial
2024 Standout
Works of Vanda Salutari being referenced
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis
2022
Ovarian Cancer Treatments Strategy: Focus on PARP Inhibitors and Immune Check Point Inhibitors
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Vanda Salutari | 694 | 531 | 386 | 101 | 1.4k | |
| Janusz Emerich | 781 | 457 | 433 | 101 | 1.5k | |
| Jacob Korach | 839 | 540 | 533 | 95 | 1.6k | |
| Chad M. Michener | 531 | 371 | 478 | 96 | 1.5k | |
| Salvatore Lopez | 604 | 528 | 589 | 88 | 1.5k | |
| Hidekatsu Nakai | 628 | 412 | 394 | 74 | 1.2k | |
| A. Pfleiderer | 502 | 417 | 361 | 102 | 1.4k | |
| Toshiko Jobo | 1042 | 627 | 704 | 70 | 1.7k | |
| Sabrina Chiara Cecere | 506 | 595 | 251 | 65 | 1.4k | |
| Chad A. Hamilton | 646 | 297 | 547 | 66 | 1.4k | |
| Radoslav Chekerov | 676 | 404 | 291 | 102 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...